Army Liposome Formulation (ALF) Phase 2 and 3 Clinical Trials
Posted Date:
Sep 25, 2024
Due Date:
Oct 05, 2024
Awarded Date:
Sep 20, 2024
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| HT942524Q0107 | Army Liposome Formulation (ALF) Phase 2 and 3 Clinical Trials | |
| Synopsis | ||
|
Army Liposome Formulation (ALF) Phase 2 and 3 Clinical Trials .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE HEALTH AGENCY (DHA) | AWARD Notice | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| HT942524Q0107 | Army Liposome Formulation (ALF) Phase 2 and 3 Clinical Trials | |
| Synopsis | ||
|
Army Liposome Formulation (ALF) Phase 2 and 3 Clinical Trials .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE HEALTH AGENCY (DHA) | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| HT942524Q0107 | Army Liposome Formulation (ALF) Phase 2 and 3 Clinical Trials | |
| Synopsis | ||
|
Army Liposome Formulation (ALF) Phase 2 and 3 Clinical Trials .... Read More
|
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| DEFENSE HEALTH AGENCY (DHA) | Combined Synopsis/Solicitation | |
